BLISS GVS PHARMA
Back to Cashflow Statement
|
BLISS GVS PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹139 Cr | ₹106 Cr | ₹103 Cr | ₹34 Cr | ₹135 Cr |
What is the latest Cash Flow from Operating Activities ratio of BLISS GVS PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹139 Cr |
| Mar2025 | ₹106 Cr |
| Mar2024 | ₹103 Cr |
| Mar2023 | ₹34 Cr |
| Mar2022 | ₹135 Cr |
How is Cash Flow from Operating Activities of BLISS GVS PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹139 Cr | 30.97 | |
| Mar2025 | ₹106 Cr | 3.01 | |
| Mar2024 | ₹103 Cr | 199.64 | |
| Mar2023 | ₹34 Cr | -74.67 | |
| Mar2022 | ₹135 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹6,693.2 Cr | 10.3% | 35.2% | 279.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,180.0 Cr | 1.6% | -1% | 22.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,302.0 Cr | 1.7% | 10.1% | 49.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,623.0 Cr | 1.5% | -1.2% | 38.2% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | 0.7% | -3.5% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,741.0 Cr | -1.3% | 0.1% | -7.8% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 10.3% |
35.2% |
279.3% |
| SENSEX | -0.9% |
-1.5% |
-5.8% |
You may also like the below Video Courses